MafF Antikörper (Middle Region)
Kurzübersicht für MafF Antikörper (Middle Region) (ABIN453173)
Target
Alle MafF (MAFF) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- This antibody reacts to MAFF.
-
Aufreinigung
- Saturated Ammonium Sulfate (SAS) precipitation
-
Immunogen
- KLH conjugated synthetic peptide selected from the Center region of human MAFF
-
-
-
-
Applikationshinweise
-
ELISA: 1/1,000. Western blotting: 1/50 - 1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MafF (MAFF) (Transcription Factor MafF (MAFF))
-
Andere Bezeichnung
- MAFF
-
Hintergrund
- MAFF is a basic leucine zipper (bZIP) transcription factor that lacks a transactivation domain. It is known to bind the US-2 DNA element in the promoter of the oxytocin receptor (OTR) gene and most likely heterodimerizes with other leucine zipper-containing proteins to enhance expression of the OTR gene during term pregnancy. This protein can also form homodimers, and since it lacks a transactivation domain, the homodimer may act as a repressor of transcription.Synonyms: Transcription factor MafF, v-maf musculoaponeurotic fibrosarcoma oncogene homolog
-
Gen-ID
- 23764
-
NCBI Accession
- NP_036455
-
UniProt
- Q9ULX9
-
Pathways
- Myometrial Relaxation and Contraction
Target
-